{"disease":{"id":"the-aim-of-this-study-is-to-follow-up-short-term-3-6-months-mid-term-6-12months-outcomes-of-vascular-access-native-and-synthetic-in-esrd-pediatrics","name":"the aim of this study is to follow up short term 3 6 months mid term 6 12months outcomes of vascular access native and synthetic in esrd pediatrics"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06034717","title":"Primary Patency in Pediatric Patients With Hemodialysis Access","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Alaa Gameil Abd El-salam Hussien","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}